Objective There is no definite consensus regarding the treatment and guidance for individuals with highnormal fasting plasma glucose levels (FPG;100-109 mg/dL). The present study aimed to determine the risk factors for future diabetes in Japanese people with high-normal FPG. Methods Retrospective cohort studies were conducted from 2008 to 2012, including 15,097 individuals who underwent medical examinations. First, the participants were divided into normal FPG (n=13,065) and highnormal FPG (n=2,032) groups to compare the diabetes incidence. Second, the high FPG group was divided into diabetes onset (n=133) and non-diabetes onset (n=1,899) groups to compare the baseline values. Third, to determine the risk factors for future diabetes in the high-normal FPG group, multivariate analyses were conducted. Results The cumulative incidence during the mean follow-up of 4 years was 94/13,065 (0.72%) and 133/ 2,032 (6.55%) in the normal FPG and high-normal FPG groups, respectively. Within the high-normal FPG group, the baseline body mass index, waist circumference, triglycerides, FPG, alanine aminotransferase (ALT), and gamma-glutamyl transferase were significantly higher and high-density lipoprotein cholesterol (HDL-C) was significantly lower in the diabetes onset group than in the non-diabetes onset group. Obesity, abdominal obesity, hypertriglyceridemia, low HDL-C, and high ALT were significant risk factors for diabetes according to a multivariate analysis. Conclusion The high-normal FPG group had a higher risk of diabetes than the normal FPG group, particularly when accompanied with obesity, abdominal obesity, hypertriglyceridemia, low HDL-C, and high ALT. Thus, this high risk group should receive appropriate guidance for lifestyle changes to avoid developing diabetes at an early stage.
Introduction
Diabetes has become a global social and economic problem. The International Diabetes Federation (IDF) reported that there are 382 million patients with diabetes, which will potentially increase to 592 million patients by 2030 (1) . In Japan, the results of the National Health and Nutrition Examination Survey in 2012 indicated that the number of patients with diabetes, those strongly suspected of having diabetes, or those with preliminary diabetes had increase to approximately 20.50 million people by 2012, accounting for one-sixth of the entire population (2). Type 2 diabetes, which develops based on lifestyle choices such as dietary intake and exercise, accounts for 95% of all of the patients with diabetes in Japan; therefore, the challenge for the future is to prevent the onset of type 2 diabetes.
In 2003, the American Diabetes Association (ADA) re-duced the threshold for normal fasting plasma glucose (FPG) from the conventional 110 mg/dL to 100 mg/dL (3) . However, the European Diabetes Epidemiology Group (EDEG) proposed that the threshold be kept at 110 mg/dL because there was insufficient evidence to change the threshold to 100 mg/dL, and consensus regarding the identification of impaired FPG based on this change was lacking; the onset of impaired FPG was estimated to increase 2 to 5-fold if this change was implemented (4) . Therefore, in 2006, the World Health Organization (WHO), jointly with the IDF, proposed that 110 mg/dL should continue to be used as the cut-off for normal FPG (5) . This reduced threshold was also adopted in the international criteria for metabolic syndrome (6) . Based on these arguments, the Japan Diabetes Society (JDS) in 2008 used 100-109 mg/dL to identify "high-normal FPG", within the normal range of <110 mg/ dL (7) . No definite conclusions have been reached regarding the treatment and guidance for high-normal FPG, which differ by scientific society and institute. Moreover, although a number of studies have investigated the onset of diabetes, few reports have so far evaluated the risk factors for the future development of diabetes with high-normal FPG (100-109 mg/dL) in Japan.
The objective of this study was to determine the risk factors for future diabetes in Japanese people with high-normal FPG.
Materials and Methods
Of 40,208 individuals aged 40-75 years who underwent medical examinations in 2008 at the Miyazaki Prefectural Health Foundation, the sample included 20,217 individuals who also underwent medical examinations in 2012 at the same institute. Of the 20,217 individuals, those who did not undergo fasting blood sampling, with an FPG ! 110 mg/dL, or undergoing treatment for diabetes in 2008 were excluded, resulting in a sample of 15,097 participants. Because only a small proportion of participants underwent glycated hemoglobin (HbA1c) measurements at baseline, HbA1c had to be excluded from the diagnostic criteria. None of the 4,722 participants (31.3%) who underwent HbA1c testing in 2008 had an HbA1c level ! 6.5% [National Glycohemoglobin Standardization Program (NGSP)].
The retrospective cohort studies were conducted with the sample of 15,097 participants. First, the participants were placed in one of two groups to compare the laboratory findings and the risk of developing diabetes in the future (Study 1): normal FPG group, n=13,065; high-normal FPG group, n=2,032. Next, the 2,032 participants in the high-normal FPG group were divided into a diabetes onset group and non-diabetes onset group to compare the baseline values (Study 2). The risk factors for future diabetes were investigated using logistic regression analyses for those in the high-normal FPG group (Study 3).
Diabetes was diagnosed at the medical examination in 2012 if FPG was ! 126 mg/dL, HbA1c was ! 6.5% (NGSP), or the participants were taking oral hypoglycemic medications or insulin. The presence of each condition was defined as follows: obesity, body mass index (BMI) ! 25.0 kg/m 2 ; abdominal obesity, waist circumference ! 85 cm (men) or ! 90 cm (women) (8); hypertension, systolic blood pressure ! 140 mmHg and/or diastolic blood pressure ! 90 mmHg or taking antihypertensive agents (9); hypertriglyceridemia, triglycerides ! 150 mg/dL; low high-density lipoprotein cholesterol (HDL-C), <40 mg/dL; high low-density lipoprotein cholesterol (LDL-C), ! 140 mg/dL (10); high aspartate aminotransferase (AST), ! 31 U/L; high alanine aminotransferase (ALT), ! 31 U/L; and high γ-glutamyl transpeptidase (γ-GTP), ! 51 U/L (11).
In Studies 1 and 2, χ 2 tests were used to compare nominal variables, and the Shapiro-Wilk test was used to test the normality and homoscedasticity of continuous variables. Because none of the continuous variables met these assumptions, Mann-Whitney U tests were used to compare the continuous variables. Two-sided p values <0.05 were considered to be significant.
In Study 3, a multivariate logistic regression analysis using the stepwise method with likelihood ratio testing was used to determine factors associated with the onset of diabetes. One analysis was conducted using the continuous variables. A second analysis was conducted using the prevalences of the conditions as nominal variables, however FPG was included as a continuous variable. Before conducting the logistic regression analysis, Spearman's rank-correlation coefficients were determined to confirm that no combination of variables had a high correlation (r>0.9).
Because HbA1c was rarely measured in the participants who underwent fasting blood collection in 2008, this was excluded as a factor. All data were digitized, and a statistical analysis was conducted using the SPSS 22 software program (IBM Corp, Armonk, USA).
This study was conducted in accordance with the "Helsinki Declaration" and "Ethical Guidelines for Epidemiology Research" and commenced upon acquiring approval from the Medical Research and Ethics Committee of Yokohama City University (July 24, 2014).
Results

Study 1: Comparison of the laboratory findings and diabetes onset after 4 years between the normal fasting plasma glucose and high-normal fasting plasma glucose groups
This study included 8,078 men and 7,019 women aged 53.1±8.27 years old. The proportion of men in the highnormal FPG group (1,404/8,078, 17.4%) was significantly higher than the proportion of women (628/7,019, 8.9%) (χ 2 test, p<0.001). In the high-normal FPG group, age, BMI, waist circumference, blood pressure, triglycerides, LDL-C, AST, ALT, and γ-GTP were significantly higher in the high- Data are reported as medians (25th-75th percentile) or number (%)* 1 . Comparisons were conducted using Mann-Whitney U tests. BMI: body mass index, HDL-C: high-density lipoprotein cholesterol, LDL-C: low-density lipoprotein cholesterol, FPG: fasting plasma glucose, AST: aspartate aminotransferase, ALT: alanine aminotransferase, -GTP: -glutamyl transpeptidase normal FPG value group (all variables, p<0.001), and HDL-C was significantly lower (p<0.001) ( Table 1) .
During the mean follow-up of 4 years, 227 participants were diagnosed with diabetes (Table 1) . Significantly more participants in the high-normal FPG group (133/2,032, 6.55%) were diagnosed with diabetes than in the normal FPG group (94/13,065, 0.72%) [odds ratio (OR), 9.7; 95% confidence interval (CI), 7.4-12.6; p<0.001].
Study 2: Comparisons between the diabetes onset and non-diabetes onset groups after 4 years in the high-normal fasting plasma glucose group
In Study 2, there were 2,032 (1,404 men, 628 women) participants aged 55.3±7.74 years old (diabetes onset, n= 133; non-diabetes onset, n=1,899). The cumulative incidence of diabetes was 7.1% (99/1,404) in men and 5.4% (34/628) in women, which was not significantly different (χ 2 test, p= 0.168). Of the baseline variables in 2008, BMI, waist circumference, triglycerides, FPG, ALT, and γ-GTP were significantly higher in the diabetes onset group (all variables, p! 0.001). HDL-C was significantly lower in the diabetes onset group (p<0.001, Table 2 ). The median blood pressure, LDL-C, and AST values were higher in the diabetes onset group, but these were not significant.
The prevalence of obesity, abdominal obesity, hypertriglyceridemia, low HDL-C, and high ALT were significantly higher in the diabetes onset group (Figure) . The incidences of hypertension, high AST, and high γ-GTP tended to be higher in the diabetes onset group, but these were not significant. The incidence of high LDL-C was similar between the two groups.
Study 3: Risk factors for the onset of diabetes among those in the high-normal fasting plasma glucose group
According to the first multivariate logistic regression analysis using the continuous variables, model 1 resulted in BMI, triglycerides, and FPG as significant variables (Table 3). This was a model χ 2 test <0.01 with p=0.559 by Hosmer-Lemeshow testing, indicating conformity along with a differential predictive value of 93.4%.
A strong correlation existed between triglycerides and HDL-C (r=-0.539); although this correlation was <0.9, model 2 excluded triglycerides from the variables included in model 1. BMI, HDL-C, and FPG were the significant variables in this model (Table 3) .
A strong correlation existed between BMI and waist circumference (r=0.848) in model 1 therefore, model 3 excluded BMI from the variables that were included in model 1. Waist circumference, triglycerides, and FPG were the independent variables in this model (Table 3) .
Therefore, BMI, waist circumference, triglycerides, and HDL-C were significant risk factors for diabetes. Moreover, as FPG increased, so did the risk of future diabetes, even within the high-normal FPG group.
According to the second logistic regression analysis using the prevalence of the conditions, abdominal obesity (OR, 1.91; 95% CI, 1.30-2.80) and hypertriglyceridemia (OR, 2.17; 95% CI, 1.50-3.14) were significant variables in model 1 (Table 4) . This was a model χ 2 test <0.01 with p=0.634 by Hosmer-Lemeshow testing, indicating conformity along with a differential predictive value of 93.4%.
According to the first multivariate logistic regression analysis, a strong correlation existed between triglycerides and HDL-C. Therefore, model 2 excluded hypertriglyceride- Table 4) . Therefore, obesity, abdominal obesity, hypertriglyceridemia, low HDL-C, and high ALT were significant risk factors for future diabetes in the high-normal FPG group. Although the continuous ALT findings were not evaluated in the first logistic regression analysis, a high ALT level was a significant risk factor in this analysis.
Finally, an additional effect of the risk factors on probability of diabetes onset was examined by using model 2, in which 3 factors, including abdominal obesity, high ALT, and low HDL-C, were adopted into the logistic regression equation in this order. The obtained equation was as follows: dependent variable Y=-3.078+0.653×(abdominal obesity)+ 0.502×(high ALT)+0.814×(low HDL-C). The probability of diabetes onset (p) was calculated according to the following formula: p=1 / [1 + Exp (-1×Y)]. The p value of diabetes onset was 0.08 for 1 risk factor (abdominal obesity), 0.13 for 2 risk factors (abdominal obesity and high ALT), and 0.25 for 3 risk factors (abdominal obesity, high ALT, and low HDL-C). These findings clearly demonstrate that increasing the number of risk factors induced a higher probability of diabetes onset, indicating a summation effect of these risk factors on diabetes onset.
Discussion
In this retrospective cohort study of Japanese people with a mean follow-up of 4 years, 6.5% of the high-normal FPG group (100-109 mg/dL) developed diabetes, with a OR for diabetes of 9.67 (7.49-12.6) compared with the normal FPG group (<100 mg/dL).
Although the JDS considers normal FPG as <110 mg/dL, the JDS also determined that people with FPG within the 100-109 mg/dL range should be considered a different group, still within the normal range, regarding the risk of diabetes and degree of glucose tolerance (7) . Several studies have shown that the number of people with FPG ! 100 mg/ dL who develop diabetes was significantly higher than those with FPG <100 mg/dL in Japanese people (12) (13) (14) (15) as well as in people from various countries (16) (17) (18) .
For example, the OR, adjusted for age and sex, for developing diabetes after a 5-year-follow-up in Japanese school teachers was 13.0 with high-normal FPG, compared with normal FPG (14) . Although age, sex and nationality differed between these studies, the ORs for the incidence of diabetes with high-normal FPG were significantly higher than those with normal FPG. Thus, people with high-normal FPG have a significantly higher risk of developing future diabetes and should be considered separately from those with normal FPG. Moreover, in the current study, as FPG increased even within the high-normal FPG group, so did risk of future diabetes via the mechanism of insufficient insulin secretion and/or increased insulin resistance.
One of the main problems with reducing the threshold of normal FPG to 100 mg/dL is the marked increase in the number of those with impaired fasting glucose (4). However, the high-normal FPG group still had an appreciable risk of future diabetes in the present study. Therefore, it is necessary to establish the significant risk factors in people with high-normal FPG, which included obesity, abdominal obesity, hypertriglyceridemia, low HDL-C level, and high ALT level in the present study.
In the high-normal FPG group in the present study, the median FPG was only 2 mg/dL higher in the diabetes onset group than in the non-diabetes onset group (Table 2) . However, as shown in each model in Table 3 , a multiple logistic regression analysis revealed that this small but significant increase in FPG may contribute to an increased risk of future diabetes, indicating the importance of FPG among the risk factors for diabetes.
Previous studies have reported that obesity is strongly correlated with the onset of diabetes (19) , and waist circumference (20, 21) and elevated liver enzymes (22, 23) are risk factors for future diabetes in people without diabetes. As expected, higher BMI, larger waist circumference, and higher ALT at baseline were associated with a higher risk of future diabetes in the high-normal FPG group in present study. High liver enzymes indicate fatty changes in the liver, and ALT might be a significant predictive factor for future diabetes in those with high-normal FPG. Regarding BMI and waist circumference, when they were treated as continuous variables, BMI had a stronger correlation with diabetes onset than waist circumference. However, when using cut-off values, abdominal obesity resulted in a greater risk of diabetes onset than overall obesity identified by BMI, which is similar to the findings of a previous study (24) . Particularly in those with high-normal FPG accompanied by obesity and abdominal obesity, guidance for lifestyle changes should be provided at an early stage to prevent the onset of diabetes. One such change could be weight loss; the risk of diabetes reportedly decreases if obese patients with an impaired fasting glucose level lose weight (25, 26) , with a reduction of 5-10% from their original weight (27) .
Hypertriglyceridemia and low HDL-C were significantly associated with the risk of diabetes in those with highnormal FPG in present study. There was a more than 2-fold difference in the adjusted OR between those with dyslipidemia and without dyslipidemia. Because a low fat/high carbohydrate diet increases triglycerides and reduces HDL-C (28), it is possible that a low fat/high carbohydrate diet is related to the onset of diabetes. Moreover, a decline in the serum adiponectin levels was a significant risk factor for the onset of type 2 diabetes in a prospective cohort study with Japanese people (29) , and serum adiponectin levels have been negatively correlated with triglyceride levels and positively correlated with HDL-C levels (30) . Dyslipidemia is a common complication in patients with diabetes; in contrast, when high triglyceride and low HDL-C levels are present in people without diabetes, insulin resistance could be predicted using the serum adiponectin levels.
This study is associated with some limitations. First, glucose tolerance testing was not performed at our institute; therefore, glucose tolerance, including postprandial blood glucose levels, was not evaluated, although glucose tolerance testing is recommended in those with high-normal FPG. Therefore, it is possible that some patients with diabetes were neither identified nor included. Second, only one prefecture was included; therefore, regional differences in characteristics could not be considered. Also, not all of the patients with diabetes necessarily had type 2 diabetes. In addition, because few patients underwent HbA1c measurements at baseline, HbA1c had to be excluded as a variable despite its predictive ability for the future development of diabetes. Therefore, the reproducibility might be affected with just the use of FPG. Another limitation is not excluding patients who received treatment for hypertension, dyslipidemia, or fatty liver. There were significantly more patients in the diabetes onset group taking hypertension drugs at baseline; however, there was no significant difference between the two groups in the presence of hypertension, which was also defined by the use of hypertension drugs, according to the χ 2 test. Therefore, hypertension was not a significant risk factor in this study. No significant difference between the diabetes onset and non-diabetes onset groups was observed regarding the use of dyslipidemia therapeutic drugs.
In conclusion, the high-normal FPG group had a higher risk of future diabetes compared with the normal FPG group, particularly when accompanied by obesity, abdominal obesity, hypertriglyceridemia, low HDL-C, and high ALT. Early intervention to achieve lifestyle changes are effective in those at high risk of diabetes. Therefore, this high risk group should be provided appropriate guidance to implement lifestyle changes to avoid developing diabetes at an early stage.
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